P0 (Pzero) Antibodies
Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.
This test was developed and its performance characteristics determined by IMMCO. It has not been cleared or approved by the U.S. Food and Drug Administration.
Antibodies against P0 at 30kD protein occur in 46% of patients with Meniere’s disease, 40% of patients with otosclerosis, 28% of patients with sudden deafness and in 4% of control subjects. (Tomasi JP, Lona A, Deggouj N, Gersdorff M. Autoimmune sensorineural hearing loss in young patients: an exploratory study. Laryngoscope, 2001;111:2050-3v)
Test Performed By: IMMCO Diagnostics, Inc.
640 Ellicott Street
Buffalo, NY 14203